<< Previous article
Advances in Food Saf...
Next article > >
Pharma Microbiology ...

5th Annual European Microbiome Congress

5th Annual European Microbiome Congress

: 13 Nov 2019 - 14 Nov 2019

: London, United Kingdom

Sector: Clinical, Microbiome, Pharmaceutical

Type: Conference


The European Microbiome Congress returns to London for its 5th year on 13th - 14th November – and this time the spotlight will be on extra-intestinal diseases and the metabolic and immune system factors that intertwine them: Neurological diseases and the gut-brain axis, the gut microbiota’s role in cancer and metabolic conditions.

There is an ever-increasing understanding of the molecular mechanisms and bacterial metabolites responsible in disease pathology, opening a huge potential for the development of LBPs (both single strain and consortia) and drug molecules to modulate the microbiome and provide a therapeutic response in a clinical setting.

 

At this year's congress: 

  • The latest pre-clinical data on the possible molecular mechanism and cross-talk between microbes, gut and brain in Parkinson’s disease from Professor Aletta Kraneveld of Utrecht University.
  • Mechanisms of action for single strain LBP approach for cancer treatment - as Imke Mudler (4D Pharma) shares their Immuno-oncology program including pre-clinical and clinical data.
  • The interaction of animal protein intake and the gut microbiota profile from T2D Karine Clement (ICAN Institute).
  • and more.....

Find out more

Venue

London
United Kingdom


Organizer

Kisaco Research
Phone: +44 (0)20 3696 2920
Email: events@kisacoresearch.com
Visit: https://kisacoresearch.com


<< Previous article
Advances in Food Saf...
Next article > >
Pharma Microbiology ...